Crossref
αvβ6-Integrin targeted Ga-68-Trivehexin PET/CT in HNSCC and PDAC patients – Interim report of a Phase 2 study
Nuklearmedizin - NuclearMedicine · 01.03.2024 · 63 (02) · 98
DOI: 10.1055/s-0044-1782307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.03.2024. Verfasst von S. S. Das und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Das, S. S., Sen, I. B., Notni, J., Malik, D., & Thakral, P. (2024). αvβ6-Integrin targeted Ga-68-Trivehexin PET/CT in HNSCC and PDAC patients – Interim report of a Phase 2 study. Nuklearmedizin - NuclearMedicine, 63(02), 98. https://doi.org/10.1055/s-0044-1782307
Vancouver
Das SS, Sen IB, Notni J, Malik D, Thakral P. αvβ6-Integrin targeted Ga-68-Trivehexin PET/CT in HNSCC and PDAC patients – Interim report of a Phase 2 study. Nuklearmedizin - NuclearMedicine. 2024;63(02):98. doi:10.1055/s-0044-1782307
BibTeX
@article{Das2024,
author = {Das, S. S. and Sen, I. B. and Notni, J. and Malik, D. and Thakral, P.},
title = {αvβ6-Integrin targeted Ga-68-Trivehexin PET/CT in HNSCC and PDAC patients – Interim report of a Phase 2 study},
journal = {Nuklearmedizin - NuclearMedicine},
year = {2024},
volume = {63},
number = {02},
pages = {98},
doi = {10.1055/s-0044-1782307}
}
EUVIMED